624 related articles for article (PubMed ID: 25728134)
21. Antigenic and genetic characteristics of zoonotic influenza viruses and development of candidate vaccine viruses for pandemic preparedness.
Wkly Epidemiol Rec; 2013 Oct; 88(42):449-63. PubMed ID: 24159668
[No Abstract] [Full Text] [Related]
22. Is It Possible to Develop a "Universal" Influenza Virus Vaccine? Potential Target Antigens and Critical Aspects for a Universal Influenza Vaccine.
Krammer F; García-Sastre A; Palese P
Cold Spring Harb Perspect Biol; 2018 Jul; 10(7):. PubMed ID: 28663209
[TBL] [Abstract][Full Text] [Related]
23. Antigenic and genetic characteristics of zoonotic influenza viruses and development of candidate vaccine viruses for pandemic preparedness.
Wkly Epidemiol Rec; 2013 Mar; 88(11):117-25. PubMed ID: 23544238
[No Abstract] [Full Text] [Related]
24. Trends in development of the influenza vaccine with broader cross-protection.
Stropkovská A; Janulíková J; Varecková E
Acta Virol; 2010; 54(1):7-19. PubMed ID: 20201609
[TBL] [Abstract][Full Text] [Related]
25. Broadly protective influenza vaccines: design and production platforms.
Elbahesh H; Saletti G; Gerlach T; Rimmelzwaan GF
Curr Opin Virol; 2019 Feb; 34():1-9. PubMed ID: 30497050
[TBL] [Abstract][Full Text] [Related]
26. Swine influenza virus: zoonotic potential and vaccination strategies for the control of avian and swine influenzas.
Thacker E; Janke B
J Infect Dis; 2008 Feb; 197 Suppl 1():S19-24. PubMed ID: 18269323
[TBL] [Abstract][Full Text] [Related]
27. Antigenic and genetic characteristics of zoonotic influenza viruses and development of candidate vaccine viruses for pandemic preparedness.
Wkly Epidemiol Rec; 2012 Oct; 87(42):401-12. PubMed ID: 23113329
[No Abstract] [Full Text] [Related]
28. Antigenic and genetic characteristics of zoonotic influenza viruses and development of candidate vaccine viruses for pandemic preparedness.
Wkly Epidemiol Rec; 2012 Mar; 87(11):97-108. PubMed ID: 22462204
[No Abstract] [Full Text] [Related]
29. Epitope-based approaches to a universal influenza vaccine.
Gottlieb T; Ben-Yedidia T
J Autoimmun; 2014 Nov; 54():15-20. PubMed ID: 25172355
[TBL] [Abstract][Full Text] [Related]
30. Pandemic H1N1 influenza virus-like particles are immunogenic and provide protective immunity to pigs.
Pyo HM; Masic A; Woldeab N; Embury-Hyatt C; Lin L; Shin YK; Song JY; Babiuk S; Zhou Y
Vaccine; 2012 Feb; 30(7):1297-304. PubMed ID: 22207090
[TBL] [Abstract][Full Text] [Related]
31. Influenza: prospect for prevention and control.
Williams JR; Chen PY; Cho CT; Chin TD
Kaohsiung J Med Sci; 2002 Sep; 18(9):421-34. PubMed ID: 12515400
[TBL] [Abstract][Full Text] [Related]
32. The Global Threat of Animal Influenza Viruses of Zoonotic Concern: Then and Now.
Widdowson MA; Bresee JS; Jernigan DB
J Infect Dis; 2017 Sep; 216(suppl_4):S493-S498. PubMed ID: 28934463
[TBL] [Abstract][Full Text] [Related]
33. Vaccines to protect humans from pandemic avian influenza strains.
Campbell JD
Md Med; 2006; 7(1):15-8. PubMed ID: 16613361
[TBL] [Abstract][Full Text] [Related]
34. Vaccine approaches conferring cross-protection against influenza viruses.
Vemula SV; Sayedahmed EE; Sambhara S; Mittal SK
Expert Rev Vaccines; 2017 Nov; 16(11):1141-1154. PubMed ID: 28925296
[TBL] [Abstract][Full Text] [Related]
35. M2e-based universal influenza vaccines: a historical overview and new approaches to development.
Mezhenskaya D; Isakova-Sivak I; Rudenko L
J Biomed Sci; 2019 Oct; 26(1):76. PubMed ID: 31629405
[TBL] [Abstract][Full Text] [Related]
36. [Immunity against influenza virus infection].
Takada A
Nihon Rinsho; 2010 Sep; 68(9):1625-30. PubMed ID: 20845738
[TBL] [Abstract][Full Text] [Related]
37. Influenza vaccines: the good, the bad, and the eggs.
Schultz-Cherry S; Jones JC
Adv Virus Res; 2010; 77():63-84. PubMed ID: 20951870
[TBL] [Abstract][Full Text] [Related]
38. Novel G3/DT adjuvant promotes the induction of protective T cells responses after vaccination with a seasonal trivalent inactivated split-virion influenza vaccine.
van de Sandt CE; Kreijtz JH; Geelhoed-Mieras MM; Vogelzang-van Trierum SE; Nieuwkoop NJ; van de Vijver DA; Fouchier RA; Osterhaus AD; Morein B; Rimmelzwaan GF
Vaccine; 2014 Sep; 32(43):5614-23. PubMed ID: 25140929
[TBL] [Abstract][Full Text] [Related]
39. Evaluation of multivalent H2 influenza pandemic vaccines in mice.
Lenny BJ; Sonnberg S; Danner AF; Friedman K; Webby RJ; Webster RG; Jones JC
Vaccine; 2017 Mar; 35(10):1455-1463. PubMed ID: 28189402
[TBL] [Abstract][Full Text] [Related]
40. Understanding immunity to influenza: implications for future vaccine development.
Tripp RA
Expert Rev Vaccines; 2023; 22(1):871-875. PubMed ID: 37794732
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
